Figure 1.

Impact of AMD on QoL as presented by utility values corresponding to VA in the better seeing eye, compared with utility values for other disease states.

Note: This figure is created from a table in an article by Brown et al, entitled, “The burden of age-related macular degeneration: a value-based medicine analysis” in Trans Am Ophthalmol Soc. 2005;103:173–184.⁶ Adapted with permission from the American Ophthalmological Society.

Abbreviations: AMD, age-related macular degeneration; QoL, quality of life; VA, visual acuity; Mi, myocardial infarction; CHF, congestive heart failure.